Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/164727
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors

AuthorsVarela, Ignacio CSIC ORCID; Menendez, Pablo; Sanjuan-Pla, Alejandra
KeywordsCancer genomics
Oncology practice
Intratumoral heterogeneity
Tumor evolution
Bioinformatics
Issue Date2017
PublisherImpact Journals
CitationOncotarget 8(39): 66742-66746 (2017)
AbstractThis meeting held at the University of Barcelona in March 2017, brought together scientists and clinicians worldwide to discuss current and future clinico-biological implications of intratumoral heterogeneity (ITH) and subclonal evolution in cancer diagnosis, patient stratification, and treatment resistance in diagnosis, treatment and follow-up. There was consensus that both longitudinal and tumor multi-region studies in matched samples are needed to better understand the dynamics of ITH. The contribution of the epigenome and microenvironment to ITH and subclone evolution remains understudied. It was recommended to combine computational, pathology and imaging tools to study the role of the microenvironment in subclone selection/ evolution.
Publisher version (URL)https://doi.org/10.18632/oncotarget.20279
URIhttp://hdl.handle.net/10261/164727
DOI10.18632/oncotarget.20279
Identifiersdoi: 10.18632/oncotarget.20279
e-issn: 1949-2553
Appears in Collections:(IBBTEC) Artículos

Files in This Item:
File Description SizeFormat
intratumor.pdf619,93 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

3
checked on Dec 2, 2021

WEB OF SCIENCETM
Citations

10
checked on Dec 1, 2021

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.